GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sunrest Lifescience Ltd (NSE:SUNREST) » Definitions » Net Income From Continuing Operations

Sunrest Lifescience (NSE:SUNREST) Net Income From Continuing Operations : ₹22.1 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sunrest Lifescience Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sunrest Lifescience's net income from continuing operations for the three months ended in Sep. 2024 was ₹0.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was ₹22.1 Mil.

Sunrest Lifescience Net Income From Continuing Operations Historical Data

The historical data trend for Sunrest Lifescience's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunrest Lifescience Net Income From Continuing Operations Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
1.37 2.24 10.50 27.44 5.93

Sunrest Lifescience Quarterly Data
Mar20 Mar21 Mar22 Dec22 Mar23 Jun23 Sep23 Mar24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only - 9.74 12.35 - -

Sunrest Lifescience Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹22.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sunrest Lifescience Ltd (NSE:SUNREST) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:544312 BOM:501477 BOM:513430 NSE:MONOPHARMA BOM:543594 BOM:543499 HKSE:06618 WBA HKSE:00241 TSE:3088 JSE:CLS TSE:3349 SHSE:603939 BSP:RADL3 SAU:4164 TSE:3391 TSE:7649 TSE:9989 TSE:3141 MEX:FRAGUAB
Traded in Other Exchanges
N/A
Address
Vastral Road, FF-41, Ajay Tenament-6 Near Canal, Near Ritanagar Bus Stand, Ahmedabad, GJ, IND, 382415
Website
https://www.sunrestlifescience.com
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products on a wholesale and retail basis. It deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises Analgesic & Anti Pyretic3030, Antacid Anti Emetics1414, Anti Biotics1717, Anti Cough & Cold4343, Anti Fungal2929, Anti Spasmodic & Enzyme99, Creams & Ointments44, Eye, Ear Drops & Nasal Spray88, General Products2828, Glucose & Energy Drink88, Hair Care77, Lady Care55, Multi Vitamins & Haemantinics3030, Oral Care55, Skin Care2222, and Vigor and Vitality.

Sunrest Lifescience Headlines

No Headlines